Literature DB >> 30063187

Telepractice Treatment of Stuttering: A Systematic Review.

Megann McGill1, Natasha Noureal1, Jordan Siegel1.   

Abstract

Purpose: The purpose of the current systematic review is to (1) guide and inform speech language pathologists involved in the treatment of persons who stutter in the development and implementation of live-stream, video telepractice services and (2) identify areas for future research related to telepractice and stuttering. Materials and
Methods: Systematic searches of electronic databases, reference lists and journals identified seven studies that met predetermined inclusion criteria. These seven studies were analyzed and summarized in terms of the: (1) sample size, (2) characteristics of the participants, (3) technology and equipment utilized, (4) clinical setting, (5) treatment type, (6) research methodology, (7) results of the study, and (8) Oxford evidence-based practice levels.
Results: Telepractice was used by university-based researchers and educators in the delivery of services to 80 participants who stutter. The services delivered included implementation of the Camperdown Program, the Lidcombe Program, and an integrated treatment approach.
Conclusion: Live-stream, video telepractice appears to be a promising service- delivery method for treatment of stuttering using the Camperdown Program, Lidcombe Program, and integrated approaches. Further research is needed to determine if the initial evaluation and diagnosis of stuttering can be made using telepractice methodologies.

Entities:  

Year:  2018        PMID: 30063187     DOI: 10.1089/tmj.2017.0319

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  8 in total

Review 1.  Non-pharmacological interventions for stuttering in children six years and younger.

Authors:  Åse Sjøstrand; Elaina Kefalianos; Hilde Hofslundsengen; Linn S Guttormsen; Melanie Kirmess; Arne Lervåg; Charles Hulme; Kari-Anne Bottegaard Næss
Journal:  Cochrane Database Syst Rev       Date:  2021-09-09

2.  Normative Values of Client-Reported Outcome Measures and Self-Ratings of Six Voice Parameters via the VoiceEvalU8 App.

Authors:  Elizabeth U Grillo; Brigit Corej; Jeremy Wolfberg
Journal:  J Voice       Date:  2021-12-09       Impact factor: 2.300

3.  Proactive changes in clinical practice as a result of the COVID-19 pandemic: Survey on use of telepractice by Quebec speech-language pathologists.

Authors:  J Macoir; C Desmarais; V Martel-Sauvageau; L Monetta
Journal:  Int J Lang Commun Disord       Date:  2021-08-29       Impact factor: 2.909

4.  A Nonrandomized Trial for Student Teachers of an In-Person and Telepractice Global Voice Prevention and Therapy Model With Estill Voice Training Assessed by the VoiceEvalU8 App.

Authors:  Elizabeth U Grillo
Journal:  Am J Speech Lang Pathol       Date:  2021-02-01       Impact factor: 2.408

5.  A Preliminary Comparison of In-Person and Telepractice Evaluations of Stuttering.

Authors:  Megann McGill; Jordan Siegel; Natasha Noureal
Journal:  Am J Speech Lang Pathol       Date:  2021-05-31       Impact factor: 2.408

6.  Feasibility and Acceptability of Clinical Pediatric Telerehabilitation Services.

Authors:  Kelly Tanner; Rachel Bican; Jamie Boster; Catie Christensen; Candace Coffman; Kristin Fallieras; Rene Long; Christine Mansfield; Sara O'Rourke; Lindsey Pauline; Grace Sagester; James Marrie
Journal:  Int J Telerehabil       Date:  2020-12-08

7.  Factors influencing the success of telepractice during the COVID-19 pandemic and preferences for post-pandemic services: An interview study with clinicians and parents.

Authors:  Elaine Yuen Ling Kwok; Kinga Pozniak; Barbara Jane Cunningham; Peter Rosenbaum
Journal:  Int J Lang Commun Disord       Date:  2022-07-23       Impact factor: 2.909

8.  Review of Systematic Reviews in the Field of Telemedicine.

Authors:  Saeideh Goharinejad; Sadrieh Hajesmaeel-Gohari; Nazanin Jannati; Samira Goharinejad; Kambiz Bahaadinbeigy
Journal:  Med J Islam Repub Iran       Date:  2021-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.